Hypertension, Hypoglycemia, Hypokalemia, Increased circulating ACTH level, Increased circulating cortisol level, Increased urinary cortisol level, Infertility, Metabolic alkalosis, Oligomenorrhea, Oligospermia, Precocious puberty, Stroke, obsolete Decreased circulating aldosterone level

abnormal branching involved in terminal bronchiole morphogenesis, abnormal calcium ion homeostasis, abnormal cecum morphology, abnormal heart echocardiography feature, abnormal humoral immune response, abnormal interferon level, abnormal interleukin level, abnormal interleukin-6 secretion, abnormal lung development, abnormal mammary gland alveolus morphology, abnormal mammary gland growth during pregnancy, abnormal myocardial fiber physiology, abnormal osteoblast differentiation, abnormal osteoblast physiology, abnormal physiological response to xenobiotic, abnormal pulmonary alveolus epithelial cell morphology, abnormal pulmonary alveolus morphology, abnormal respiratory system development, abnormal response to CNS ischemic injury, abnormal surfactant secretion, abnormal thoracic cavity morphology, abnormal thymocyte apoptosis, abnormal tumor necrosis factor level, absent adrenal medulla, absent adrenergic chromaffin cells, absent circulating adrenaline, absent long term depression, adipose tissue phenotype, behavior/neurological phenotype, behavioral despair, cardiac fibrosis, cardiac hypertrophy, cardiovascular system phenotype, cecum inflammation, decreased CD4-positive, alpha beta T cell number, decreased T cell apoptosis, decreased adrenaline level, decreased anxiety-related response, decreased body length, decreased body size, decreased cardiac muscle contractility, decreased circulating noradrenaline level, decreased double-positive T cell number, decreased locomotor activity, decreased macrophage cell number, decreased noradrenaline level, decreased physiological sensitivity to xenobiotic, decreased single-positive T cell number, decreased survivor rate, decreased susceptibility to neuronal excitotoxicity, decreased thymocyte apoptosis, decreased type I pneumocyte number, dilated heart left ventricle, endocrine/exocrine gland phenotype, enlarged adrenocortical cell nuclei, enlarged adrenocortical cells, enlarged myocardial fiber, growth/size/body region phenotype, heart inflammation, homeostasis/metabolism phenotype, hypersecretion of corticotropin-releasing hormone, immune system phenotype, impaired lung alveolus development, increased adrenocorticotropin level, increased body length, increased circulating angiotensinogen level, increased circulating glucocorticoid level, increased heart weight, increased interleukin-1 beta secretion, increased left ventricle weight, increased liver triglyceride level, increased lung weight, increased mean systemic arterial blood pressure, increased renin activity, increased sensitivity to induced morbidity/mortality, increased susceptibility to endotoxin shock, increased susceptibility to experimental autoimmune encephalomyelitis, increased systemic arterial systolic blood pressure, increased type II pneumocyte number, lethality, complete penetrance, neonatal lethality, complete penetrance, neonatal lethality, incomplete penetrance, nervous system phenotype, no abnormal phenotype detected, pathological neovascularization, perinatal lethality, complete penetrance, perinatal lethality, incomplete penetrance, poor circulation, postnatal lethality, complete penetrance, premature death, pulmonary hyperplasia, renal/urinary system phenotype, skeleton phenotype, small adrenal glands, thick pulmonary interalveolar septum, thick ventricular wall, thin adrenal cortex